Fondazione I.R.C.C.S. Policlinico San Matteo — Pavia

Public research footprint of Fondazione I.R.C.C.S. Policlinico San Matteo, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

AL Amyloidosis · Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) · Acute Graft Versus Host Disease in Intestine · Obstructed Biliary and Pancreatic Duct

Recently updated registry entries

NCT06465953 — Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With… (Recruiting)
NCT04910685 — (HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With… (Recruiting)
NCT06016842 — A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Fondazione I.R.C.C.S. Policlinico San Matteo?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.